Label reading

What It Means When A Supplement Prints No Supplement Facts Panel

Most bottles on a supplement shelf carry a small black-ruled table on the back. Some do not, and the difference decides almost everything a buyer can work out for themselves. This is what the table does, what its absence costs, and what can still be learned from a label without one.

By Primal Grow Pro Team · Last updated October 29, 2026 · 9 min read · Label reading · Reviewed by Dr. Jonathan Clavell, MD

What the panel actually is

The Supplement Facts panel is a standardised table. Its format is prescribed, which is the point of it: whatever the product, the information sits in the same places, so a reader who has learned to read one has learned to read all of them.

The top line gives the serving size and how many servings the container holds. Beneath it runs one row per active ingredient with an amount per serving. Where a reference intake exists, a per cent Daily Value sits alongside. Underneath the ruled box comes the other-ingredients line, which is where the capsule shell, the fillers and the flow agents are declared.

The part people underestimate

Everything a buyer might want to calculate depends on the first two rows. Cost per day needs the serving size. Whether an ingredient is present at a researched level needs its amount. Whether a second supplement would double something needs both. The panel is not paperwork; it is the arithmetic surface of the product.

And the part that gets skipped

The other-ingredients line is read least and answers questions people care about most. Gelatin or hypromellose settles the vegetarian question in one word. A badge on the front implies that answer; the line beneath the panel states it.

Why most bottles carry one

A panel exists partly because buyers expect it and partly because it is the cheapest credibility a manufacturer can buy. A company confident in its formula gains from printing the numbers, because the numbers are the argument.

That logic runs the other way too, and it is worth stating without heat. A product whose amounts are modest has an incentive not to print them. A buyer outside the company cannot tell which situation a blank space represents, which is the whole difficulty. The systematic review of ingredients in popular male supplements found the published evidence behind finished products in this category to be absent, and where evidence is thin the incentive to publish a number is thinner.

The five things lost without it

Five rows that a conventional panel carries. Two of the five are answered on this pack, and both of those are about supply rather than about contents.

Reading down the third column, five specific capabilities disappear with the panel and they are worth naming individually rather than as a general complaint.

• Comparison with the research. An ingredient’s literature belongs to the amount the trials used, and there is nothing to line a label up against.
• Comparison between products. Two bottles naming the same seven botanicals could differ tenfold in every row and look identical on their fronts.
• Stacking safety. Somebody taking a second supplement cannot tell whether they are doubling an ingredient, because neither label gives them a number to add.
• The shell material. No other-ingredients line means no answer about gelatin or hypromellose, which is the question behind every vegetarian badge on a capsule.
• A basis for an assay. A laboratory reports what it found against what the label declared. With nothing declared, a measurement has nothing to be measured against.

What can still be learned

A label without a panel is not a blank object. Four things remain readable and three of them are useful.

The serving and the count are usually printed on the front, and between them they fix the supply. Thirty capsules at one a day is a month, which turns a price into a cost per day and a pack into a period. That is real information and it is the basis of every sensible comparison of value in this category.

The legal category is printed too. The words DIETARY SUPPLEMENT place the product under a regime that permits structure and function statements and forbids disease claims, which tells a reader what the strongest honest sentence about it can be.

The names are worth something too. Knowing that a formula contains St. John’s wort matters whether or not an amount is printed.

The trial dose as a substitute, and its limits

If a label gives no figure, the only quantitative context available is the figure the published research used. Printing that beside each name is the honest substitute for a panel, and it is what this website does across every page.

The right-hand column belongs to other products in other trials. It is printed here because it is the only quantitative context available, and it is labelled as somebody else’s figure every time it appears on this website.

Two limits on that table deserve to be stated as plainly as the table itself.

It is somebody else’s figure. The bacopa trials that produced the 300 mg figure used a standardised extract prepared to a fixed bacoside content. A capsule containing unstandardised bacopa at 300 mg is not the same purchase, and one containing an unknown amount is not comparable at all.

And the scales do not match each other. Huperzine research runs in micrograms, ginkgo and bacopa in hundreds of milligrams, carnitine and glutamine in grams. A single capsule cannot hold all seven at their researched amounts, which is arithmetic rather than an accusation, and it is the most useful thing the right-hand column establishes.

What assays found when there WAS a declared figure

The strongest argument for a panel is not theoretical. Two published studies opened bottles in this category and measured what was inside, comparing the result against what each product declared on itself.

The first examined 22 US brain-health products carrying huperzine A. Servings ran from below the limit of quantification to 267 micrograms, and only two of the twenty-two came within 10 per cent of their own declared amount.

The second examined 23 US supplements carrying vinpocetine. Servings ran from 0.3 mg to 32 mg, a hundredfold spread, and six of the twenty-three contained none at all.

Both findings are about products that DID print a number. The number is what made the discrepancy visible, which is the uncomfortable symmetry at the centre of this subject: a missing panel is not evidence of a problem, and it is the condition under which a problem would be invisible.

Six questions worth asking a seller

• What is the amount of each named ingredient per capsule?
• Which plant part is used for each botanical, and to what is each extract standardised?
• What is the capsule shell made of?
• What is in the other-ingredients line, if there is one?
• Has any lot been assayed by an independent laboratory, and can that report be read?
• Why is no Supplement Facts panel printed?

Those six are reasonable, they are answerable, and the answers a company gives to them are informative whatever they contain. A seller who answers the first two in detail is telling you something. A seller who answers none of them is telling you something as well.

NCCIH’s guidance on using supplements sensibly makes the related point: whoever manages your health should know what you are taking. Where you cannot name amounts, name the ingredients instead.

What would fix this in one revision

A single artwork revision would change almost everything on this page, and it would not be an expensive one. A Supplement Facts panel with a figure for each of the seven names would make the trial-dose comparison a real comparison rather than a substitute, would make three more checks on any label scorecard answerable, and would let an independent assay mean something.

Two smaller additions would do disproportionate work alongside it: a capsule shell material, which settles the vegetarian badge in a word, and a caution line naming St. John’s wort.

Until then, the honest description of a bottle like this is a real product with a real routine and real terms of sale, whose contents cannot be checked by anybody outside the company that makes it. A buyer who finds that acceptable is making an informed decision, and so is a buyer who does not.

References